| An observational disease and clinical outcomes registry of patients with acid lipase (LAL) deficiency |
Ongoing |
Kanuma |
4 |
ALX-LALD-5 |
King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz Medical City NG (Riyadh) |
| A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature |
Ongoing |
Sogroya , Norditropin |
3 |
NN8640-4467 |
King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz Medical City NG (Riyadh) |
| Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients A Prospective, Multi-Centre, Double-Blind, Randomized, Controlled Trial. SPICE IV |
Ongoing |
DEXMEDETOMIDINE |
4 |
SCT21R/006/04 |
King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh) |
| VICTORION REAL: An international prospective Real-world study to evaluate the Effectiveness and Adherence of incLisiran plus standard of care lipid-lowering therapy compared to standard of care therapy alone in patients with primary hypercholesterolemia or mixed dyslipidemia |
Ongoing |
Inclisiran |
4 |
CKJX839A12 |
Saud Al-Babtain Cardiac Center (Dammam) , King Salman Armed Forces Hospital(Tabuk) , King Fahd Armed Forces Hospital (Jeddah) , Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh),King Faisal Specialist Hospital and Research Center (Jeddah), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), International Medical Center (Jeddah) |
| The effect of novel D3 use as a mouthwash in COVID-19 patients |
Rejected |
D3 mouthwash |
4 |
2022-32 |
King Faisal Specialist Hospital and Research Center (Jeddah) |
| O-SEMA-Fast: A research study to understand how oral semaglutide works in people with type 2 diabetes who plan to fast during Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait |
Ongoing |
Semaglutide |
4 |
NN9924-757 |
Almoosa Specialist Hospital (Alahsa) |
| Study on Clinical Use of EVUSHELD (AZD7442) as Pre-exposure Prophylaxis in the Real-world Setting – A Multi-centre Observational Prospective Study to Determine the Utilisation and Clinical Outcomes of EVUSHELD in Middle East and Africa |
Ongoing |
EVUSHELD |
4 |
D8851R0000 |
King Saud Medical City (Riyadh) |
| A REGISTRY TO COLLECT CHARACTERISTICS AND OUTCOMES FROM PATIENTS WITH SOLID TUMORSPROFILED WITH A NEXT-GENERATION SEQUENCINGTEST (WAYFIND-R) |
Ongoing |
NA |
4 |
MX39897 |
King Abdulaziz Medical City NG (Riyadh) |
| Real-World Experience of Upadacitinib in Moderate to Severe Atopic Dermatitis |
Ongoing |
Upadacitinib (Rinvoq) |
4 |
H23-107 |
King Faisal General Hospital (Makkah), Mohammed Dossary Hospital - Al Khobar, King Fahad Central Hospital (Jazan), East Jeddah General Hospital, Hira Hospital (Makkah) , Aseer Central Hospital (Abha) |
| Articaine efficacy and safety for 3 years old children: A Clinical Randomized Control Trial. |
Ongoing |
Articaine |
3 |
607-43-7809 |
Qassim Regional Dental Center |
